Lost password ?
Dallah Healthcare
A better leverage in Q4
- "Dallah healthcare has reported an accelerated Q4 leading to close the FY19 with sales of SAR1,252m (+6%). Margins have markedly improved thanks to a better performance from Namar hospital. "
Executive summary
Conflicts of Interest
Pages 39
Language English
Publish on March 4, 2020
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.